Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4078253
Max Phase: Preclinical
Molecular Formula: C44H54Cl2N12O7
Molecular Weight: 933.90
Molecule Type: Small molecule
Associated Items:
ID: ALA4078253
Max Phase: Preclinical
Molecular Formula: C44H54Cl2N12O7
Molecular Weight: 933.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(Cl)c(CN(NC(=O)[C@H](C)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](N)Cc2cnc[nH]2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(N)=O)c(Cl)c1
Standard InChI: InChI=1S/C44H54Cl2N12O7/c1-25(53-42(62)38(17-27-21-51-35-13-7-6-12-30(27)35)55-41(61)34(48)18-28-22-50-24-52-28)40(60)57-58(23-31-32(45)19-29(65-2)20-33(31)46)44(64)56-37(16-26-10-4-3-5-11-26)43(63)54-36(39(49)59)14-8-9-15-47/h3-7,10-13,19-22,24-25,34,36-38,51H,8-9,14-18,23,47-48H2,1-2H3,(H2,49,59)(H,50,52)(H,53,62)(H,54,63)(H,55,61)(H,56,64)(H,57,60)/t25-,34-,36-,37+,38+/m0/s1
Standard InChI Key: LQJKFRSJNPMROR-HBPJJVMHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 933.90 | Molecular Weight (Monoisotopic): 932.3615 | AlogP: 2.26 | #Rotatable Bonds: 22 |
Polar Surface Area: 297.57 | Molecular Species: BASE | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.86 | CX Basic pKa: 10.45 | CX LogP: 0.48 | CX LogD: -2.03 |
Aromatic Rings: 5 | Heavy Atoms: 65 | QED Weighted: 0.04 | Np Likeness Score: -0.16 |
1. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD.. (2017) Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators., 60 (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209] |
Source(1):